SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)
PFE 24.65+1.5%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: runningelk who wrote (1650)2/26/2000 1:28:00 PM
From: Rob Loney  Read Replies (1) of 1722
 
I can't believe the buying opportunity for BMY right now!

I work in sales for a competing pharmaceutical company, and all of my customers are drooling at the prospect of the soon to be launched Omapatrilat.

I've been told by investigators in double-blinded trials, that "you can't blind me to the effect of this drug". It's that much better at lowering blood pressure than anything else available. This drug has multiple mechanisms, and has the ability to dramatically increase NO synthesis (the key to protection against the complications of Coronary Artery Disease).

Studies to further demonstrate it's superiority will be presented at the American college of Cardiology Meeting in Anaheim, March 10-16.

Look for a run up at this point, or even sooner if the FDA "Fast- Tracked" approval comes through sooner than the early April expectation.

Omapatrilat, which has completed late stage phase 3 studies, will be the "Lipitor" of blood-pressure lowering. (If you're not aware, Lipitor does $4 billion yearly in North America). In my opinion, the lay people who are out chasing the biotech sector, and buying anything with the word "gene" in it have completely lost it.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News